TransMedics Group Inc vs Energy Select Sector SPDR Fund — how do they compare? TransMedics Group Inc trades at $86.5 (market cap $3.00B), while Energy Select Sector SPDR Fund trades at $65.67. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| TMDX | XLE | |
|---|---|---|
Market Cap | $3.00B | — |
Sector | Technology | — |
52-Week High | $150.42 | $65.31 |
52-Week Low | $61.99 | $42.61 |
Enterprise Value | $3.39B | — |
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported strong 2025 results with $605M revenue and 31.4% net margin, though 2026 projections show margin compression. Recent news highlights growth initiatives in kidney transplantation and European markets, alongside ongoing legal investigations into fiduciary duties.
The stock offers upside to the $99.57 consensus price target, supported by analyst bullishness (69% buy ratings), but faces risks from margin pressure, legal scrutiny, and earnings misses. Revenue growth remains a key catalyst, though execution risks and investor sentiment headwinds warrant caution.
XLE, the Energy Select Sector SPDR ETF, trades at $64.78, up 1.12% amid bullish technical signals and strong sector momentum. The ETF benefits from rising oil prices, with Brent crude exceeding $100 per barrel due to Middle East tensions, as reported by Reuters on September 9, 2026. Technical indicators show a bullish moving average consensus, though the 6-day RSI at 78.15 suggests potential overbought conditions. Recent performance includes a 7.4% gain in August, leading sector ETFs, per ETF Trends on September 2, 2026.
Outlook remains positive driven by geopolitical supply risks and institutional optimism, with Goldman Sachs forecasting oil could reach $120 (Zacks, September 8, 2026). Key risks include oil price volatility and refining capacity constraints. The ETF's concentration in large caps like Exxon and Chevron offers stability, but investors face exposure to energy market cyclicality.
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →